RVPH icon

Reviva Pharmaceuticals
RVPH

Overview Fund Activity

23 hedge funds and large institutions have $15.4M invested in Reviva Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
2
Closed
5
Calls
$12.5M
Puts
$2.47M
Net Calls
+$10.1M
Net Calls Change
+$9.61M

Top Buyers

1
AC
Armistice Capital
New York
$4.83M
2
Millennium Management
Millennium Management
New York
$2.69M
3
Citadel Advisors
Citadel Advisors
Florida
$488K
4
CG
Colony Group
Massachusetts
$908K
5
Vanguard Group
Vanguard Group
Pennsylvania
$3.61M

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
2
TCM
Tang Capital Management
California
$0
3
SM
Sabby Management
Florida
$0
4
Bank of New York Mellon
Bank of New York Mellon
New York
$0
5
Goldman Sachs
Goldman Sachs
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
26
Sabby Management
Florida
– -$120K -28,610 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$63K -15,047 Closed
Goldman Sachs
28
Goldman Sachs
New York
– -$51.3K -12,236 Closed
1
2